MedTrace Logo

Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence

NCT02819336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2017-06-27

No results posted yet for this study

Summary

This pilot protocol is aimed to evaluate the effectiveness and safety of electroacupuncture therapy for the post-stroke patients with urinary incontinence.

Conditions

Interventions

DEVICE

Electroacupuncture (EA)

The EA group will receive the verum therapies using the following procedures. 1. Let the patient lie down on lateral decubitus. 2. The practitioners install the same guide-tubes as Park sham needle on CV2, CV3, CV4, CV6 and bilateral points of SP11 and SP6. 3. The verum acupunctures are inserted on each acupoint inside the installed guide-tube. (stainless steel, 0.25 mm in diameter and 4.0 mm in length, Dong Bang Acupuncture Inc., Republic of Korea) 4. After de qi response is elicited, the electrical stimulation is presented for 20 minutes by middle frequency (30 Hz). (STN-111, Stratek, Republic of Korea) 5. The practitioner should have at least 1-year clinical experiences. The procedure will be repeated 10 times (once a session) within 21 days.

DEVICE

Sham electroacupuncture

1. Let the patient lie down on lateral decubitus. 2. The practitioners install the same guide-tubes as Park sham needle on CV2, CV3, CV4, and CV6 unilaterally \& SP11 and SP6 bilaterally. 3. The non-penetrating sham acupunctures are implemented on each acupoint inside the installed guide-tube. 4. The electrical stimulation is presented for 20 minutes by middle frequency (30 Hz), (STN-111, Stratek, Republic of Korea) even though the electrical stimulation is not delivered through the skin because the needles are not penetrated through the skin. 5. The practitioner should have at least 1-year clinical experiences. The procedure will be repeated 10 times (once a session) within 21 days.

Sponsors & Collaborators

  • Wonkwang University Gwangju Medical Center

    collaborator UNKNOWN

  • Kyunghee University

    lead OTHER

Principal Investigators

  • Euiju Lee, Ph.D. · Kyunghee University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-04-30
Completion
2017-06-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819336 on ClinicalTrials.gov